Angelika Dr. Imhof
About Angelika Dr. Imhof
Angelika Dr. Imhof is the Country Medical Director for Germany at BeiGene, with extensive experience in medical and marketing roles across various pharmaceutical companies.
Current Position at BeiGene
Angelika Dr. Imhof serves as the Country Medical Director for BeiGene in Germany, based in München und Umgebung, Deutschland. In her role, she oversees medical strategies, clinical development, and medical affairs for the company in Germany. Her responsibilities also include ensuring compliance with medical regulations and fostering relationships with key opinion leaders (KOLs).
Previous Roles and Experience
Angelika Dr. Imhof's previous roles include Medical Director DACH & Italy at Clovis Oncology from 2018 to 2020 in Munich, and Senior Medical Director DACH & Poland at Jazz Pharmaceuticals from 2015 to 2018 in München. She also worked as Medical Director at EUSA Pharma, an International Division of Jazz Pharmaceuticals from 2013 to 2014, Director EMEA Marketing, New Indications at Celgene from 2010 to 2013 in Boudry, Switzerland, and Global Head of Marketing Biopharmaceuticals at Sandoz International from 2009 to 2010 in Holzkirchen, Germany.
Educational Background
Angelika Dr. Imhof received her Doctor of Medicine (MD) degree from the University Hospital Munich Grosshadern. Her education has provided her with a strong scientific foundation and extensive knowledge in oncology, hematology, and dermato-oncology. This educational background has supported her career in both local and international medical affairs, enhancing her expertise in strategic medical and marketing roles.
Key Competencies and Skills
Angelika Dr. Imhof is known for her highly developed tactical medical and marketing skills, strategic thinking, and analytical abilities in medical affairs. She has extensive experience in KOL development and portfolio planning. Additionally, her broad scientific knowledge base in oncology, hematology, and dermato-oncology, combined with operational excellence, has made her a key figure in the field.